Muscle loss may slow hip replacement recovery — a trial tests whether exercise can help

NCT ID NCT07734129

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether screening older adults for sarcopenia (loss of muscle strength and mass) before hip replacement surgery, followed by a structured exercise program after surgery, can improve recovery. Participants aged 65 and older with advanced hip osteoarthritis will be divided into groups: those with sarcopenia who receive the exercise program, those with sarcopenia who receive standard care, and those without sarcopenia who receive standard care. The study aims to see if early detection and targeted rehabilitation can lead to better muscle strength, physical function, and quality of life after hip replacement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a supervised group physical rehabilitation program including stretching, cycling, and strengthening exercises
What this could lead to
If it works, this could point toward a standard approach to identify and treat muscle weakness before and after hip replacement, improving mobility and quality of life for older adults.
What could go wrong
This is a relatively small trial, and the exercise program is short (2 months). Results may not apply to all patients or settings, and adherence to the program could vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COXARTHROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • FIMABIS

    Málaga, 29007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.